Cefepirome Inj. 1 Gm Cephalosporins (Dry Powder Injection) Vial

What is Cefepirome Inj. 1 Gm Cephalosporins (Dry Powder Injection) Vial?

Cefepirome Injection 1 Gm is a cephalosporin antibiotic presented as a dry powder injection. Cefepirome is a fourth-generation cephalosporin that acts against susceptible bacteria by interfering with bacterial cell-wall synthesis. Its clinical use depends on the approved product information, the type of bacterial infection and the susceptibility of the causative organism.

Uses / Indications

Cefepirome is an antibacterial medicine intended for selected bacterial infections caused by susceptible organisms. Its use should be guided by the applicable approved prescribing information and local clinical guidelines.

Potential clinical considerations may include:

• Selected serious bacterial infections caused by susceptible organisms.

• Certain hospital-associated infections where cefepirome is an approved treatment option.

• Other bacterial infections only where supported by the specific product information and susceptibility results.

The precise approved indications vary by product and jurisdiction. Confirm the authorised indications for this formulation before publication or clinical use. Cefepirome does not treat viral infections such as influenza or the common cold.

6. Benefits

• Contains cefepirome, an established cephalosporin antibacterial active ingredient.

• Supplied in a dry powder injection presentation.

• Provides an injectable formulation for use in appropriate clinical settings.

• Can be considered for susceptible bacterial infections when supported by the approved prescribing information.

• Kelar Pharmachem India supports pharmaceutical sourcing and export requirements, subject to product availability and destination-market requirements.

Clinical suitability depends on the causative organism, susceptibility, patient characteristics and professional assessment.

7. Side Effects

The occurrence and severity of adverse effects depend on the patient, dose and approved product formulation.

Common Side Effects

Potential adverse effects associated with cephalosporin antibiotics may include:

• Nausea or vomiting.

• Diarrhoea.

• Skin rash.

• Injection-site discomfort or reactions.

The frequency and relevance of these effects should be confirmed from the cefepirome-specific prescribing information.

Less Common or Serious Side Effects

Potential clinically important risks that require assessment against the product-specific information include:

• Serious allergic reactions, including anaphylaxis.

• Severe or persistent antibiotic-associated diarrhoea, including possible Clostridioides difficile infection.

• Changes in blood cell counts or liver function tests.

• Kidney-related complications in susceptible patients.

• Neurological reactions, depending on the medicine, dosage and patient factors.

Seek prompt medical assessment if a serious allergic reaction, severe diarrhoea or another significant adverse reaction is suspected. Refer to the approved product information for the complete safety profile.

8. How Does It Work?

Cefepirome belongs to the beta-lactam group of antibiotics and is classified as a fourth-generation cephalosporin. It binds to bacterial penicillin-binding proteins and interferes with the synthesis of peptidoglycan, a structural component of the bacterial cell wall. This weakens the cell wall and can lead to the death of susceptible bacteria.

Its activity depends on the susceptibility of the causative organism. It does not work against viral infections, and appropriate clinical assessment helps determine whether it is suitable.

9. Dosage Guidelines

The dosage of Cefepirome Injection depends on the infection being treated, its severity, the causative organism, patient age and weight where relevant, renal function and the approved prescribing information.

• The supplied strength is 1 Gm.

• The appropriate dose and dosing interval must be determined by a qualified healthcare professional.

• Renal impairment may affect dosage requirements.

• Reconstitution, dilution and administration must follow the product-specific approved instructions.

• Preparation and administration must be carried out by appropriately qualified healthcare professionals.

The exact dose and treatment duration should follow the approved product information and the recommendation of a qualified healthcare professional.

10. When Not to Use

Cefepirome should not be used in patients with a known serious hypersensitivity to cefepirome or any other component for which the approved product information specifies a contraindication.

Before administration:

• Review the patient’s history of allergy to cephalosporins.

• Assess previous serious reactions to penicillins or other beta-lactam antibiotics.

• Review renal function and other relevant clinical factors.

• Follow the contraindications stated in the approved product information.

A penicillin allergy does not automatically contraindicate every cephalosporin. A qualified healthcare professional should assess the type and severity of any previous reaction.

11. Drug / Product Interactions

Potential interactions should be reviewed using the cefepirome-specific prescribing information and the patient’s current medication list.

Clinical review may consider:

• Other medicines that may affect renal function.

• Other antibiotics, where combination treatment is being considered.

• Anticoagulants or medicines requiring additional monitoring, where relevant to the specific product information.

• Medicines or laboratory procedures associated with documented product-specific interactions.

These are considerations for professional review rather than confirmed interactions for every cefepirome product. Healthcare professionals should consult the full prescribing information before use.

12. Safety Advice

• Use only under appropriate medical supervision.

• Confirm the product identity and strength before administration.

• Review the patient’s allergy history.

• Assess renal function where clinically indicated.

• Follow the approved preparation and administration instructions.

• Monitor for allergic reactions and other clinically significant adverse effects.

• Use antibiotics only for appropriate bacterial indications to support antimicrobial stewardship.

Pregnancy, breastfeeding and paediatric use should be assessed according to the applicable product information and the patient’s clinical circumstances.

13. General Instructions

• Verify the product name, strength, batch number and expiry date.

• Inspect the vial and container closure for damage.

• Follow the approved instructions for reconstitution and administration.

• Maintain appropriate aseptic handling practices.

• Do not use damaged containers or products that fail applicable quality checks.

• Confirm compatibility before mixing with other medicines.

• Follow product-specific instructions for use and storage after reconstitution.

• Dispose of unused medicine and clinical waste in accordance with applicable procedures.

Do not assume a universal diluent, reconstitution volume, administration method or post-reconstitution stability period.

14. Special Dietary / Lifestyle Tips

No universal dietary restriction can be established specifically for Cefepirome Injection from the information supplied.

• Follow the treatment plan provided by the healthcare professional.

• Complete treatment according to the prescribed instructions.

• Do not share antibiotics with others.

• Report persistent diarrhoea, rash or other concerning symptoms promptly.

• Follow individual fluid-intake advice if renal disease or another condition requires restrictions.

Dietary and lifestyle recommendations should be tailored to the patient’s overall medical condition.

15. Comparison with Other Treatments

Cefepirome is a fourth-generation cephalosporin. Its clinical role depends on its antibacterial spectrum, the causative organism and the approved indications.

No antibiotic is universally preferable for every infection. Selection should be based on the suspected or confirmed pathogen, susceptibility results, infection site, patient factors and local treatment guidance.

16. Precautions & Warnings

• Hypersensitivity: Review previous reactions to cephalosporins and other beta-lactam antibiotics.

• Renal impairment: Assess renal function and follow any dosage adjustment requirements in the approved information.

• Antibiotic-associated diarrhoea: Severe or persistent diarrhoea requires medical assessment.

• Laboratory monitoring: Blood counts, renal function or liver function may require monitoring depending on the product information and the patient’s condition.

• Antimicrobial resistance: Avoid inappropriate use and follow local antibiotic stewardship guidance.

• Special populations: Pregnancy, breastfeeding and paediatric use require assessment according to the approved product information.

Confirm all product-specific precautions before publication.

17. Can I Use It With Other Medicines?

Whether Cefepirome Injection can be used with other medicines depends on the patient’s clinical condition, concurrent treatments and the approved product information.

Inform the healthcare professional about:

• Prescription and non-prescription medicines.

• Other antibiotics.

• Medicines that may affect renal function.

• Anticoagulants and other medicines requiring monitoring.

• Vitamins and supplements.

Physical compatibility is separate from systemic drug interactions. Do not mix cefepirome with another medicine in a syringe, infusion container or administration line unless compatibility is confirmed by approved product-specific instructions.

18. Storage

Store according to the manufacturer’s approved product labelling. Refer to the product packaging or package insert for the applicable storage conditions.

Storage requirements before reconstitution may differ from those after preparation. Any temperature limits, protection requirements and permitted period of use after reconstitution must be confirmed from the documentation for this specific product.

19. Frequently Asked Questions (FAQs)

1. What is Cefepirome Injection 1 Gm used for?

Cefepirome is an antibacterial medicine used for selected bacterial infections when supported by the approved prescribing information and susceptibility results.

2. What is the active ingredient in this product?

The supplied product name identifies cefepirome as the active ingredient.

3. What does the 1 Gm strength mean?

It identifies the stated product strength as 1 Gm. The exact labelling and quantity per vial should be confirmed against the approved product specification.

4. How is Cefepirome Dry Powder Injection prepared?

A qualified healthcare professional must prepare it according to the approved instructions. The diluent, preparation volume and administration method must be confirmed from the product-specific documentation.

5. Can cefepirome be used in patients with a penicillin allergy?

An allergy assessment is required. The healthcare professional should review the previous reaction and the product-specific contraindications before deciding whether treatment is appropriate.

6. What precautions are important before administration?

Verify the product and strength, review allergy history, assess relevant patient factors and follow the approved preparation and administration instructions.

7. How should Cefepirome Injection be stored?

Follow the manufacturer’s approved labelling. Storage conditions before and after reconstitution must be confirmed from the product-specific documentation.

8. Is Cefepirome Injection available for pharmaceutical export?

Kelar Pharmachem India is a pharmaceutical sourcing and export company. Product availability, packing, supporting documentation and destination-market requirements should be confirmed with the company.

This information is for pharmaceutical product reference and does not replace approved prescribing information or professional medical advice.